Immunofluorescence Assay for Circulating Tumor Cells Using the CellSearch System
BRD ID: 3031
Tier: SOP
Source: DCTD
Number of times downloaded: 293
Description
This document describes the immunomagnetic selection of circulating tumor cells (CTCs) and the detection of biomarkers by immunofluorescence assay using a qualified primary conjugated antibody and the CellSearch System CellTracks AutoPrep and Analyzer II. It is intended to be used in coordination with DCTD SOPs on specimen collection (LHTP00.08.03) and antibody qualification (LHTP003.8.1.1). It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD; https://dctd.cancer.gov/). Please check the DCTD website (https://dctd.cancer.gov/drug-discovery-development/assays) for the current SOP version.
Biospecimens
CellBlood
Diagnoses
NeoplasticNot specified
Topics
Biospecimen Aliquots and Components
Platform-specific Methodology